AMRN Insider Trading

Insider Ownership Percentage: 1.96%
Insider Buying (Last 12 Months): $102,400.00
Insider Selling (Last 12 Months): $0.00

Amarin Insider Trading History Chart

This chart shows the insider buying and selling history at Amarin by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200k$0$200kTotal Insider BuyingTotal Insider Selling

Amarin Share Price & Price History

Current Price: $0.44
Price Change: Price Decrease of -0.0271 (-5.80%)
As of 03/28/2025 05:00 PM ET

This chart shows the closing price history over time for AMRN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$0.44Closing price on 03/28/25:

Amarin Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Amarin (NASDAQ:AMRN)

22.25% of Amarin stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AMRN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$2.61Mbought$1.42MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$4M-$2M$0$2M$4MTotal InflowsTotal Outflows
Amarin logo
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Read More on Amarin

Today's Range

Now: $0.44
Low: $0.42
High: $0.47

50 Day Range

MA: $0.53
Low: $0.40
High: $0.64

52 Week Range

Now: $0.44
Low: $0.35
High: $1.11

Volume

1,130,697 shs

Average Volume

1,388,887 shs

Market Capitalization

$180.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.82

Who are the company insiders with the largest holdings of Amarin?

Amarin's top insider shareholders include:
  1. Aaron Berg (CEO)
  2. Steven B Ketchum (Insider)
  3. Patrick Holt (CEO)
Learn More about top insider investors at Amarin.

Who are the major institutional investors of Amarin?

Amarin's top institutional investors include:
  1. Waterfront Wealth Inc. — 0.60%
  2. Two Sigma Investments LP — 0.53%
  3. Two Sigma Advisers LP — 0.42%
  4. Longitude Cayman Ltd. — 0.39%
  5. Eversept Partners LP — 0.37%
  6. BNP Paribas Financial Markets — 0.33%
Learn More about top institutional investors of Amarin stock.

Which major investors are selling Amarin stock?

During the last quarter, AMRN stock was sold by these institutional investors:
  1. Eversept Partners LP
  2. Longitude Cayman Ltd.
  3. Two Sigma Advisers LP
  4. Two Sigma Investments LP
  5. OneDigital Investment Advisors LLC
  6. Commonwealth Equity Services LLC
  7. Cutter & CO Brokerage Inc.
  8. Ameriprise Financial Inc.

Which major investors are buying Amarin stock?

In the last quarter, AMRN stock was bought by institutional investors including:
  1. Waterfront Wealth Inc.
  2. AXA S.A.
  3. Raymond James Financial Inc.
  4. Raymond James Financial Inc.
  5. Quinn Opportunity Partners LLC
  6. Mercer Global Advisors Inc. ADV
  7. Jane Street Group LLC
  8. Sei Investments Co.
In the previous year, these company insiders have bought Amarin stock:
  1. Aaron Berg (CEO)
  2. Steven B Ketchum (Insider)
Learn More investors buying Amarin stock.